Meningitis

 

GEL GBS, E. coli, Listeria



Central Nervous System
Meningitis

Authors: Kimberly Lee, Pharm.D., Michael Stevens, M.D., M.P.H.

Last Updated: January 2019

Evaluation

Typical CSF findings with bacterial meningitis:

Opening Pressure: ≥ 20 cm H2O

WBC: 1,000-5,000 cells/mm3 (Range < 100 to > 10,000 cells/mm3) (Neutrophils > 80%)

Glucose <40 mg/dl (Ratio of CSF:Serum ≤ 0.4)

Protein >200 mg/dl (range 100-500)

Empiric Treatment: 
  

Host

Common Pathogen

Empiric Therapy

Beta-Lactam Allergy3

Age < 50

 

Community Acquired,

Non-Traumatic, Immunocompetent

N. meningitidis, 

S. pneumoniae

 

Vancomycin IV1

AND

Ceftriaxone2000 mg IV every 12 hours

 

Vancomycin IV1

AND

Aztreonam 2000 mg IV every 6 hours

Age > or = 50 

 

Community Acquired,

Non-Traumatic, Immunocompetent

N. meningitidis, 

S. pneumoniae,

L. monocytogenes, Aerobic gram-negative bacilli

Vancomycin IV1

AND

Ceftriaxone2000 mg IV every 12 hours

AND

Ampicillin2000 mg IV every 4 hours

Vancomycin IV1

AND

Aztreonam2 2000 mg IV every 6 hours

AND

Trimethoprim/Sulfamethoxazole (TMP/SMX)  5 mg/kg IV every 8 hours

Post-neurosurgery

Coagulase-negative staphylococci,

S. aureus,

Gram negative bacilli (including Pseudomonas)

Vancomycin IV1

AND

Cefepime2000 mg IV every 8 hours

Vancomycin IV1

AND

Ciprofloxacin IV 400 mg every 8 hours

AND

Aztreonam2 2000 mg IV every 6 hours

CSF shunt

S. aureus, Coagulase- negativestaphylococci, 

Gram negative bacilli (including Pseudomonas), 

P. acnes

Vancomycin IV1

AND

Cefepime2000 mg IV every 8 hours

Vancomycin IV1

AND

Ciprofloxacin IV 400mg every 8 hours

AND

Aztreonam2 2000 mg IV every 6 hours

  1. Vancomycin administered to maintain serum trough concentration of 15-20 mcg/ml.
  2. Aztreonam, Colistin, Daptomycin, and Linezolidmust be approved by ASP or ID.
  3. Optimal coverage is with a beta-lactam antibiotic. Attempts should be made to clarify the patient’s allergy. For patients with a history of maculopapular rash only to a penicillin, consideration should be given to using a cephalosporin. For patients with a true immediate hypersensitivity reaction to penicillin (hives, anaphylaxis, angioedema) beta-lactam antibiotics should be avoided. The overall risk for a true hypersensitivity reaction to penicillin is relatively low at 0.5 to 2%. Cross-reactivity between penicillins and cephalosoporins is approximately 2% and 1% for carbapenems. 

 

Use of steroids:

Dexamethasone has shown to be of benefit in suspected pneumococcal meningitis at a dose of 0.15 mg/kg IV every 6 hours for 2-4 days. This must be given 10-20 minutes before, or concomitant with, the first dose of antimicrobial therapy. If the patient has already received antimicrobial therapy, adjunctive dexamethasone is unlikely to improve outcome and should not be given.  If dexamethasone is given, consideration should be made to add Rifampin. If Streptococcus pneumoniae is not identified dexamethasone should be discontinued.

 

Specific Antimicrobial Therapy by Pathogen

Pathogen

Therapy

Alternative Therapy

Duration

Streptococcus pneumoniae

  PCN MIC<0.06 mcg/ml

 

Penicillin G 4 million units IV every 4 hours

 

 Ceftriaxone 2000 mg IV every 12 hours

 

 

10-14 days

  PCN MIC>0.12 mcg/ml

  Ceftriaxone MIC <1.0   mcg/ml

Ceftriaxone 2000 mg IV every 12 hours

Cefepime 2000 mg IV every 8 hours

  PCN MIC>0.12 mcg/ml

  Ceftriaxone MIC >1.0     mcg/ml

Vancomycin IV1

Plus

Ceftriaxone 2000 mg IV every 12 hours

**ID CONSULT HIGHLY RECOMMENDED**;

Moxifloxacin2 +/- vancomycin or Ceftriaxone

Neisseria meningitidis

PCN MIC

  <0.1 ug/ml

 

Penicillin G 4 million units IV every 4 hours

 

Ceftriaxone 2000 mg IV every 12 hours

 

 

7 days

  0.1-1.0 ug/ml

Ceftriaxone 2000 mg IV every 12 hours

Meropenem 2000 mg IV every 8 hours

Propionibacterium acnes

Penicillin G 4 million units IV every 4 hours

Ceftriaxone 2000 mg IV every 12 hours

10-14 days

Listeria monocytogenes

Ampicillin 2000 mg IV every 4 hours

TMP/SMX 5 mg/kg IV every 8 hours

21 days

Streptococcus agalactiae

Ampicillin 2000 mg IV every 4 hours

Ceftriaxone 2000 mg IV every 12 hours

14-21 days

Escherichia coli and other Enterobacteriaceae

Ceftriaxone 2000 mg IV every 12 hours

Ciprofloxacin  400 mg IV every 8 hours

10-21 days

Extended spectrum B-lactamase-producing gram-negative bacilli

Meropenem2000mg IV every 8 hours

Cefepime 2000mg IV every 8 hours or Ciprofloxacin IV400mg every 8 hours

14 days

Acinetobacter baumannii

Meropenem2000mg IV every 8 hours

Colistin (see dosing in antibiotic guide)

14 days

Pseudomonas aeruginosa

Cefepime 2000 mg IV every 8 hours

Ciprofloxacin IV400 mg every 8 hours

(encourage obtaining an ID consult)

14-21 days

Haemophilus influenzae

  beta-lactamase negative

Ampicillin 2000 mg IV every 4 hours

Ceftriaxone 2000 mg IV every 12 hours

 

7 days

  beta-lactamase positive

Ceftriaxone 2000 mg IV every 12 hours

Ciprofloxacin IV400 mg  every 8 hours

Staphylococcus aureus

MSSA

 

 

Nafcillin 2000 mg IV every 4 hours

 

Vancomycin IV1

 

 

14-21 days

MRSA

Vancomycin IV1

 

**ID CONSULT HIGHLY RECOMMENDED**;

Potential options could include: TMP/SMX  5 mg/kg IV every  8 hours, Linezolid2 600mg IV every 12 hours, Daptomycin2 8 mg/kg IV daily

Coagulase negativestaphylococci

Vancomycin IV1

Linezolid2 600mg IV every 12 hours

10-14 days

Enterococcus species

Ampicillin-susceptible

 

Ampicillin 2000 mg IV every  4 hours

Plus

Gentamicin 1.5 mg/kg IV every 8 hours(if synergy)

**ID CONSULT HIGHLY RECOMMENDED**

 

 

 

Consult ID

Ampicillin-resistant

Vancomycin IV1

Plus

Gentamicin 1.5 mg/kg IV every 8 hours (if synergy)

**ID CONSULT HIGHLY RECOMMENDED**

 

Vancomycin-resistant

**ID CONSULT HIGHLY RECOMMENDED**

 

**ID CONSULT HIGHLY RECOMMENDED**

 

 

 

1. Administer vancomycin to maintain serum trough concentration of 15-20 mcg/ml.

2. Aztreonam, Colistin, Daptomycin, Linezolid, and Moxifloxacin must be approved by ASP or ID.

 

References:

1. Practice Guidelines for the Management of Bacterial Meningitis. Clin Infect Dis 2004;39:1267-1284.

2. 2017 IDSA Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017.


Comments